Baseline dependent minimally important differences for clinical outcomes of pulmonary rehabilitation in people with COPD.
暂无分享,去创建一个
M. Spruit | A. Vaes | F. Franssen | D. Janssen | M. Groenen | E. Wouters | A. Jenkins
[1] A. Marques,et al. The presence of extra-pulmonary treatable traits increases the likelihood of responding to pulmonary rehabilitation. , 2022, Respiratory medicine.
[2] E. Wouters,et al. Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients , 2022, PloS one.
[3] A. Marques,et al. Pulmonary rehabilitation outcomes in individuals with chronic obstructive pulmonary disease: a systematic review. , 2021, Annals of physical and rehabilitation medicine.
[4] F. Cottone,et al. Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review , 2018, Health and Quality of Life Outcomes.
[5] R. Sanderman,et al. Clinically relevant differences in COPD health status: systematic review and triangulation , 2018, European Respiratory Journal.
[6] Sally J. Singh,et al. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease. , 2017, Journal of the American Medical Directors Association.
[7] J. Wedzicha,et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.
[8] E. Wouters,et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling , 2015, European Respiratory Journal.
[9] J. Aviña-Zubieta,et al. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus , 2015, Arthritis Research & Therapy.
[10] Thierry Troosters,et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.
[11] Thierry Troosters,et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.
[12] Sally J. Singh,et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement , 2014, European Respiratory Journal.
[13] J. Wedzicha,et al. Minimal clinically important differences in pharmacological trials. , 2014, American journal of respiratory and critical care medicine.
[14] E. Wouters,et al. Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial , 2014, Thorax.
[15] Sally J. Singh,et al. British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE , 2013, Thorax.
[16] L. Edwards,et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. , 2012, Journal of the American Medical Directors Association.
[17] P. Jones,et al. Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.
[18] F. Maltais,et al. Pulmonary rehabilitation in chronic obstructive pulmonary disease. , 2009, Panminerva medica.
[19] Y. Lacasse,et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD , 2007, Thorax.
[20] J. Kiley,et al. Challenges Associated with Estimating Minimal Clinically Important Differences in COPD—The NHLBI Perspective , 2005, COPD.
[21] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.
[22] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[23] G. Kwakkel,et al. Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. , 2003, Journal of cardiopulmonary rehabilitation.
[24] J. Grimshaw,et al. Research designs for studies evaluating the effectiveness of change and improvement strategies , 2003, Quality & safety in health care.
[25] T. T. Haug,et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.
[26] A. Feinstein. Indexes of contrast and quantitative significance for comparisons of two groups. , 1999, Statistics in medicine.
[27] J. O'fallon,et al. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] P. Jones,et al. The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.
[29] M. Testa. Interpreting quality-of-life clinical trial data for use in the clinical practice of antihypertensive therapy. , 1987, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[30] V. Kreinovich,et al. Why 70/30 or 80/20 Relation Between Training and Testing Sets: A Pedagogical Explanation , 2018 .
[31] E. Wouters,et al. Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis. , 2017, Journal of the American Medical Directors Association.
[32] Sally J. Singh,et al. American Thoracic Society Documents An Official American Thoracic Society / European Respiratory Society Statement : Key Concepts and Advances in Pulmonary Rehabilitation Executive Summary , 2013 .